Porphyrin metabolism was investigated in a 63-year-old male patient who developed a subacute onset polyneuropathy with predominance of motor signs in the upper limb.
Introduction
Hereditary aminolaevulinic acid dehydratase (porphobilinogen synthase) 1 ) deficiency is a very rare cause of acute hepatic porphyria. Üntil now, to our knowledgej only three homozygous knöwn cases have been reported (l, 2). Lead ititoxication, which is a common phenomenon, also causes »a loss of activity of atninoläevulinic acid dehydratase, but it is reversible by dithiothreitol or zinc ions (3).
To our knowledge, our patient had not suffered from any serious illness, even neurological or haematologicäl. Then, at the age of 63, he developed a subacute polyneuropathy for which he was hospitalized. The shoulder girdle muscles and the extensors of the wrist were severely affected, and the lower limb muscles were affected to a lesser degree. Sensory impairment was minimal. At the same time, early signs of myeloproliferative disease were found.
This study describes the contribution of biochemical investigations to the diagnosis of this rare type of porphyria. We also report the results of the investigation of the family for this enzyme defect.
Materials and Methods
Plasma and urinary 5-aminolaevulinic acid and porphobilinogen were determined spectrophotometrically, after elution from ion-exchange resins (Βίο-Rad, West Germany), according to the Mauzerall & Granick method (4), adapted s follows for plasmatic determinations: 4 ml of plasma are adjusted to pH 6.5 with acetic acid l mol/1 or NaOH l mol/1, then centrifuged. The usual procedure for urine is then followed. After ionexchange Separation, the eluate must be filtered on a Millex-SR 0.5 μηι filter (Millipore, France) before adding Ehrlich*$ reagent. Urinary porphyrins: uroporphyrin fraction, coproporphyrin fraction "and faecal porphyrins: coproporphyrin and protoporphyrin were determined spectrophotometrically after liquid extraction (5). Urinary and faecal porphyrins were separated by high performance liquid chromatography (HPLC) using a method derived from those of Ford et al. (6) and de Verneuil & Nordmann (7) . The Chromatographie System consisted of a SP 8700 solvent delivery System (Spectra-Physics, U. S. A.), a KS Nucleosil 120-5 C 18 (100 mm) column (Macherey-Nagel, West Germany), a fluorimeter Fluoromat FS 950 (Kratos, U. S. A.) s detector (excitation: 400 nm; emission: 600 nm) and a single r nge recorder BD 7 (Intersmat, U. S. A.). The internal Standard was mesoporphyrin IX dimethylester (Porphyrin products, U. S. A.). Erythrocyte zinc protoporphyrin was measured with a haematofluorometef> (8) . Urine mercury was determined by atomic absorption spectrometry according to Coyle & Hartley (13) .
Urine cadmium and thallium were determined according to Kubasik & Volosin (14) with an atomic absorption 4000 spectrometer (Perkin Eimer, U. S. A.) and a HGA 500 oven (Perkin Eimer, U. S. A.). Plasma aluminium was determined by atomic absorption spectrometry according to Valentin et al. (15) .
Urine and serum amino acid analyses were performed by an ion-exchange Chromatographie method, according to Bremer et al. (16) , using a TMS l amino acid analyser (Technicon, U. S. A.). The ethylenediaminetetraacetate (EDTA) mobilization test for lead excretion was performed by i. v. administration of 1600 mg of calcium EDTA in 30 minutes.
The red blood cell, white blood celi, platelet count, haematocrit, blood haemoglobin and white blood cell differentiation were performed with a H-l Technicon analyzer (Technicon, USA).
Plasma glucose and creatinine were performed with a Hitachi 717 analyzer (Hitachi, Japan).
Results
The investigation was started with toxicological screening for heavy metals involved in toxic polyneuropathy. The urinary levels of lead, cadmium, mercury and thallium were within the normal ranges, s were plasma lead and aluminium and the results of the EDTA lead mobiHzati n test (tab. 1).
However, the urinary screening for porphyrins indicated an increased excretion of these compounds (tab. 2).
• l Tab A more complete study of porphyrins in urine, blood and faeces, and their precursors was performed. The results obtained (tab. 2), especially the significant increase of 5-aminolaevulinate in urine and plasma with porphobilinogen concentrations within normal limits, suggested a deficiency of aminolaevulinic acid dehydratase. The activity of aminolaevulinic acid dehydratase was therefore determined in erythrocytes, in the presence and in the absence of both dithiothreitol and zinc ions s reactivators. We also determined the activity of porphobilinogen deaminase 1 ) in erythrocytes. The results obtained are presented in table 2. Tyrosinaemia was ruled out s a possible cause of aminolaevulinic acid dehydratase deficiency, because the levels of plasma tyrosine (55 μηιοΐ/ΐ) were within normal· limits (50-76 μιηοΐ/l), and urine tyrosine (81 μιηοΐ/g creatinine; reference values: 30 -220 μπιοΐ/g creatinine) was also normal. Four relatives were also studied: one sister, one brother, the daughter and the grand-daughter of the patient. The results are presented in table 3.
On admission, the erythrocyte count was 4. /1. On cytological and histological ex minati n, the p tient's bone marrow was hypercellular and had an increased number of megacaryocytes with occasional hypersegmentation of the nuclei. There was a slight loss of granulation of the granulocytes and a relative eosinophilia. The red cell line was hyperplastic. According to these results, the patient was considered to have a myeloproliferative disease of primary polycythaemia type.
Plasma glucose was 5.5 mmol/1 (reference values: 3.9 -5.8 mmol/1) and plasma creatinine was 88 μηιοΐ/ΐ (reference values: 35 -132 μπιοί/1). After oral loading with 100 g of glucose, plasma glucose was 10.8 mmol/1 after 2 hours, and 8.8 mmol/1 after 3 hours.
Discussion
The activity of aminolaevulinic acid dehydratase is most frequently reduced by a heavy metal intoxication, commonly lead, but it is also decreased in various conditions: chronic ethylism (17, 18) , cirrhosis (19) , smoking (20, 21) , renal insufficiency (22) and diabetes mellitus (23) . All these causes were ruled out in our patient by anamnestic, clinical and biochemical investigations. However, the oral glucose tolerance test was abnormal, but the plasma glucose levels remained always between normal limits during the hospitalization of the patient.
Heavy metals other than lead, i. e. aluminium (24) , inercury (25) and cadmium (26) , do not decrease the activity of aminolaevulinic acid dehydratase in concentrations that are toxic in vivo. In vitro, very much higher concentrations of these metals can cause an Inhibition (24, 27) .
A rare cause of aminolaevulinic acid dehydratase inhibition is succinylacetone, a metabolite found in tyrosinaemia (28, 29, 30 Nomial serum and urine amino acid patterns excluded tyrosinaemia, and therefore the presence of succinylacetone. The failure of dithiothreitol and zinc to restore aminolaevulinic acid dehydratase suggests a primary loss of activity of the enzyme, rather than an Inhibition by lead or succinylacetone.
We therefore presumed that our patient suffers from a primary aminolaevulinic acid dehydratase deficiency.
During the investigation of certain members of the family, we found an intermediate aminolaevulinic acid dehydratase activity in a sister, in the daughter and in the grand-daughter of the patient, which indicates that this loss of activity is hereditary (tab. 3). Our results are in accordance with an autosomal recessive inheritance, s shown in the three other cases (l, 2), although our data do not exclude an X-linked inheritance. Table 4 compares the results of biochemical investigations of pprphyrin metabolism in the homozygous patients described in the literature (l, 2) with those obtained by us. All these patients showed a strong increase of 5-aminolaevulinate in the urine, together with a mild increase or a normal level of porphoWU linogen in the urine. The plasma of our patient showed a dramatic increase of 5*aminolaevulinate and no detectable porphobilinogen. The remarkable discordance between 5-aminolaevulin te and porphobilinogen points to the existence of ap enzymatic blockade at the aminolaevulinic acid dehydratase level. This enzymatic activity was not increased by reactivators.
In all patients, the urinary porphyrin profile sfaowed a predominant coproporphyrin fraction, with a smaller incre se of the uroporphyrin fraction. This type of profile can also be observed m heavy metal intoxic tio (1). The faecal porphyrin profile was less typical than that of urine; a ^ρΓοροφΙινπη inerease was found in two patients and a protopoiphyrin increase in one patient. The erythrocyte porphyrins (protoporphyrin, zinc protophorphyrin, total porphyrins) were increased in all patients.
The porphobilinogen deaiiiinase activity in erythrpcytes was strongly increased in our patient, although no haemolytic anaemia was noticed. The three other patients, showed no increase of porphobilinogen deaminase activity. Does this represent an attempt of the cell to diminish the blockade of the enzymatic pathway by speeding up the transformation of porphobilinogen to uroporphyrinogen? On the other band, could a myeloproliferative disorder provoke some modification of haem biosynthesis? An association of porphyria cutanea tarda with a chronic granulocytic leukaemia has been described before (31, 32) .
The immunological characterization of the two patients of Doss showed a cross-reactive immunological material which corresponded to 20% and 33% of the control level (33) . Therefore the molecular basis for the deficiency of aminolaevulinic acid dehydratase in these patients is a structurally modified enzyme (33) . The methods used to determine the relative molecular mass (by Western blotting) and the isoelectric point (by chromatofocusing) of the mutants revealed no differences between the modified and normal enzymes (33) . In the patient of Thunell, the immunoreactive enzyme protein in the child's erythrocytes was decreased to 28% of the normal control, suggesting the presence of positive cross reactive material (34) . These results suggest that in these cases, the aminolaevulinic acid dehydratase deficiency is associated with the production of a catalytically abnormal enzyme protein (33, 34) .
Finally, the occurrence of the Symptoms of porphyria for the first time at the age of 63 remains an enigma. Presumably the low activity of aminolaevulinic acid dehydratase had been present since birth, and to our knowledge this patient had never presented clinical Symptoms of porphyria until the age of 63.
Conclusion
case of aminolaevulinic acid dehydratase hereditary deficiency is reported in a 63-year-old man affected by a motor polyneuropathy. The diagnosis was made: 1) from the increase of urinary and plasmatic aminolaevulinate, with non-detectable plasmatic porphobilinogen levels;
2) from the absence of heavy metal intoxication, tyrosinaemia, alcoholism, smoking, cirrhosis, renal insuficiency and diabetes mellitus;
3) from the failure to regenerate the activity of erythrocyte aminolaevulinic acid dehydratase. The familial study confirmed the hereditary autosomal recessive nature of this enzymatic deficiency.
